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Abstract 
Urological tumors diagnosed during pregnancy are rare. However, the incidence seems to be 
increasing largely due to advancements in modern imaging techniques and improved 
antenatal care. The diagnosis and management of renal tumors during pregnancy poses a 
dilemma to clinicians. This case report highlights the challenges in managing a large 
chromophobe renal cell carcinoma in a young primigravida patient. Proper antenatal 
assessment, a multidisciplinary team approach and appropriate discussion with patient are 
important determinants to achieve the best clinical outcomes for both the mother and the 
baby. 
 
 
Introduction  
 
Pregnancy-associated cancers have 
increased statistically although it remains 
rare. The incidence is reported to be one for 
every 1000 maternities (1). This increase is 
only partially explained by increasing 
maternal age. Improved imaging  
techniques and increased interaction with 
health services during pregnancy could be 
the reasons for  the detection of  higher 
rates of pregnancy-associated cancers (2) 
with renal cell carcinoma (RCC) being the 
most common. In the past, management of 
intrapartum malignancy has been 
controversial due to the difficulties in 
predicting and achieving best maternal-
fetal outcomes. However, these have 
changed recently with improvements in 
surgical techniques and intensive care 
facilities. This case report highlights the 
challenges in managing a large 
chromophobe RCC in a young primigravida 
patient. 
 
Case Report 
 
We report a case of a renal tumor 
diagnosed during the first trimester in a 
Gravida 1 Para 0, previously healthy 21-
year-old female. The renal tumor was 
diagnosed incidentally during routine 
antenatal ultrasound scan. The patient 
reported vague and mild abdominal 
discomfort of unknown duration leading up 
to her pregnancy. The abdominal 
discomfort was soon attributed by the 
patient to be pregnancy related. In 
addition, the patient lived in a regional area 
with reduced access to tertiary care. 
Following the initial antenatal scan, which 
did not reveal any renal mass, another 
abdominal ultrasound ordered by her 
General Practitioner confirmed a large left 
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Figure 1: Computed tomography of abdomen and the histology of RCC. A, Axial CT scan of left 
renal tumor occupying almost half of the abdomen (arrow). B, Coronal CT scan view of left renal 
tumor at the upper pole displacing the normal lower pole renal parenchyma (arrow). C, Hematoxylin 
and Eosin staining of the tumor showed chomophobe morphology with peri-nuclear halo and 
transitional cells. 
 
renal upper pole mass. Follow up imaging 
at 31 weeks gestation revealed a rapidly 
enlarging renal tumor, with size of 
17.0x15.0x10.0cm3. A decision was made 
by the treating medical team to defer 
definitive treatment until postpartum. 
 
A healthy baby girl was delivered via 
spontaneous vaginal delivery at term. 
Within a few days postpartum, an 
abdominal computed tomography scan 
revealed a large left heterogeneous mass 
with mixed density and contrast 
enhancement and a small indeterminate 
liver lesion (Figures 1 A and B). Open left 
radical nephrectomy was performed 3 
weeks following delivery. Intra-operatively, 
there was no evidence of metastatic disease 
and a 2086g left renal tumor measuring 
23.0x17.0x13.0 cm3 was successfully 
removed. The post-operative recovery was 
uneventful. Pathological analysis revealed 
chromophobe RCC, pT2bN0M0 with peri-
nuclear halo and transitional cells (Figure 
1 C). There was no venous infiltration and 
the tumor was CK7, CD117 positive and 
CD10 negative with no sarcomatoid or 
rhabdoid differentiation. Surgical margins 
were clear. Magnetic resonance imaging at 
one week post-operation showed a small 
liver nodule consistent with focal nodular 
hyperplasia and no appearance of typical 
metastasis in the liver (Figure 2). On follow 
up, the patient remained well with no 
evidence of recurrence or metastases.  
 
Discussion 
 
Urological tumors diagnosed during 
pregnancy are rare. Approximately 70 
cases of RCC have been reported so far (3). 
Of these, the incidence of chromophobe 
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Figure 2: T1 weighted MRI (axial view): Liver lesion consistent with focal nodular hyperplasia 
(arrow). 
 
 
RCC remained the lowest (4). RCC often 
mimics common benign pregnancy-related 
symptoms such as abdominal pain, urinary 
tract infections and urinary calculi. 
Therefore, similar symptomatology between 
an enlarging RCC and pregnancy-related 
conditions may delay the diagnosis and 
treatment of such renal tumors (5).   In the 
literature, the most common symptoms in 
pregnant women with renal cancer were: 
palpable mass (88%), pain (50%), 
hematuria (47%), fever (21%), hypertension 
(18%) while the classical triad of symptoms 
was noted in only 21% of cases (6). In our 
case, the patient did notice mild abdominal 
discomfort which was dismissed by the 
patient as pregnancy-related aches. 
 
It has been proposed that pregnancy 
related hormonal changes may act as 
promoters for renal malignancy. For 
example, high estrogen levels during 
pregnancy can promote malignant changes 
by stimulating renal cell proliferation (7). 
However, there has been no demonstrable 
immunodeficiency in pregnancy to antigens 
carried by tumor cells (8). Furthermore, in 
most cases, the biological behavior of 
malignancy is not influenced by pregnancy 
(9).  
 
The safest imaging modalities in pregnancy 
are ultrasonography and Magnetic 
Resonance Imaging (MRI) with both of them 
containing minimal risk for ionizing 
radiations. However, several factors may 
explain the delay in diagnosis of renal 
cancer in pregnancy. Most small renal 
masses are asymptomatic and further 
assessment is often not indicated largely 
because of insufficient safety data of 
radiation during pregnancy. (10). 
Radiological assessment of extra pelvic 
organs is also not part of routine antenatal 
screen. The early pregnancy scan usually 
performed before 15 weeks establishes the 
viability, gestational age, fetal number and 
gross anomalies. The anomaly scan usually 
performed at 20 weeks involves assessment 
of major organs and seek out any 
anomalies. These recommended antenatal 
scans usually focus only on the pelvic 
region and fetal structures.  
 
A full abdominal ultrasound during 
pregnancy will allow the early diagnosis of 
malignancies or diseases of other organs 
which may impact upon the well-being of 
the mother and fetus. This slight 
modification of full abdominal ultrasound 
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is fast, simple to perform, and safe for both 
fetus and mother.  Some authors 
recommend that a total abdominal 
ultrasound be performed at least once in 
all pregnancies in addition to routine fetal 
ultrasonography, especially in the presence 
of loin or abdominal pain, hematuria or 
hypertension (11, 12). Once a urological 
malignancy is detected on ultrasonography, 
the safest modality for further imaging 
studies is MRI. Radiological contrast agents 
should be avoided due to transplacental 
risk and teratogenic effects (13). In our 
case, serial ultrasound scans were used as 
MRI was not readily accessible in the 
regional center. 
 
In the case of RCC, timely diagnosis and 
management is crucial in predicting 
maternal-fetal prognosis. Timing of surgery 
for renal tumors during pregnancy is 
controversial. Recommendations regarding 
the timing of surgery are dictated by time 
of diagnosis, size and stage of tumor, 
probability of malignancy, general health of 
the mother and probability of survival of 
the fetus. Probability of cure is directly 
related to the stage of malignancy. Surgical 
resection remains the mainstay of 
treatment.  Most renal neoplasms are slow 
growing with an average volume doubling 
time of more than 500 days (4).Therefore it 
may be reasonable to await fetal delivery 
prior to surgery if the neoplasm is detected 
during late stages of pregnancy. During 
diagnosis of suspicious malignant renal 
mass in the first trimester, surgery is often 
not delayed despite the small increased 
risk of miscarriage (14). However, surgery 
during second trimester will need to 
balance the maternal and fetal risk of 
abortion and preterm labor with the risks 
of delaying surgery.  Avoidance of 
disruption of the peritoneal cavity in the 
extra-peritoneal approach may theoretically 
be associated with less uterine irritation 
and in turn fewer obstetrics complications, 
including preterm labor (15). This is 
especially critical in the management of 
small renal cancers due to increased risk of 
maternal-fetal adverse outcome before 32 
weeks gestation (16).   
 
With the discovery of renal tumor during 
third trimester, delivery followed by 
nephrectomy is recommended (17). It is 
reasonably safe to observe small renal 
masses and a short delay in definitive 
treatment in the third trimester. On the 
other hand, for large tumors, or tumors 
which exhibit very rapid growth as 
occurred in this case, nephrectomy should 
not be delayed.  If the diagnosis of renal 
tumor is near term, nephrectomy should be 
postponed till post-delivery. However, some 
physicians recommend immediate 
nephrectomy irrespective of the pregnancy 
stage. Because, they feel that the main 
priority is to the mother’s welfare (18). 
Nevertheless, in the presence of 
malignancy, maternal-fetal morbidity and 
mortality should be carefully considered 
with maternal health as the top priority 
(19). The patient needs to be thoroughly 
informed of all possible risks versus 
benefits of management options laid out 
through discussions in a multi-disciplinary 
conference (urologists, obstetricians and 
oncologists).     
 
Conclusion 
 
Routine complete abdominal ultrasound 
screening during pregnancy will benefit 
patients. Furthermore, a patient-centered 
multidisciplinary approach is preferred to 
maximize a favorable maternal-fetal 
outcome in the management of suspicious 
renal masses during pregnancy. Prompt 
diagnosis and management of RCC during 
pregnancy is important because it is 
potentially curable. 
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